Clinical Trials Directory

Trials / Unknown

UnknownNCT04471766

Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention

Evaluation of Locally Produced Cloth Face Mask on COVID-19 and Respiratory Illnesses Prevention at the Community Level - a Cluster-randomized Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40,000 (estimated)
Sponsor
Bandim Health Project · Academic / Other
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

The number of cases of COVID-19 is still increasing and transmission of SARS-CoV-2 seems to occur mainly through person-to-person transmission through respiratory droplets, indirect contact with infected people and surfaces. The use of face masks is recommended as a public health measure, but in many settings only domestic cloth made masks are available to the majority of the people. However, masks can be of different quality and very little is known about the utility of cloth face masks at the community level. In Bandim Health Project's Health and Demographic Surveillance System we will evaluate the effect of providing locally produced cloth face masks on severity of COVID-19 like illness and mortality in an urban population. The locally produced cloth mask is made according to a laboratory certified model and will be provided to the intervention group alongside information of how the risk of transmission can be reduced. The control group will receive information alone. Follow-up will be implemented through telephone calls and post-epidemic home visits.

Conditions

Interventions

TypeNameDescription
OTHERCertified cloth face mask plus preventive informationProvision of two face masks sewed locally following a certified model tested for FORCE in the laboratory per residents \> 10 years old
BEHAVIORALPreventive informationAdvice on how to prevent COVID-19 according to the government´ policy

Timeline

Start date
2020-07-20
Primary completion
2021-10-01
Completion
2021-10-01
First posted
2020-07-15
Last updated
2021-10-13

Locations

1 site across 1 country: Guinea-Bissau

Source: ClinicalTrials.gov record NCT04471766. Inclusion in this directory is not an endorsement.